BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9329463)

  • 1. Equal participation of minority patients in U.S. national pediatric cancer clinical trials.
    Bleyer WA; Tejeda HA; Murphy SB; Brawley OW; Smith MA; Ungerleider RS
    J Pediatr Hematol Oncol; 1997; 19(5):423-7. PubMed ID: 9329463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National cancer clinical trials: children have equal access; adolescents do not.
    Bleyer WA; Tejeda H; Murphy SB; Robison LL; Ross JA; Pollock BH; Severson RK; Brawley OW; Smith MA; Ungerleider RS
    J Adolesc Health; 1997 Dec; 21(6):366-73. PubMed ID: 9401854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Access to Children's Oncology Group and Pediatric Brain Tumor Consortium phase 1 clinical trials: Racial/ethnic dissimilarities in participation.
    Nooka AK; Behera M; Lonial S; Dixon MD; Ramalingam SS; Pentz RD
    Cancer; 2016 Oct; 122(20):3207-3214. PubMed ID: 27404488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood cancer in the United States. A geographical analysis of cases from the Pediatric Cooperative Clinical Trials groups.
    Ross JA; Severson RK; Pollock BH; Robison LL
    Cancer; 1996 Jan; 77(1):201-7. PubMed ID: 8630931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities.
    Stewart JH; Bertoni AG; Staten JL; Levine EA; Gross CP
    Ann Surg Oncol; 2007 Dec; 14(12):3328-34. PubMed ID: 17682824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials.
    Chen MS; Lara PN; Dang JH; Paterniti DA; Kelly K
    Cancer; 2014 Apr; 120 Suppl 7(0 7):1091-6. PubMed ID: 24643646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five National Cancer Institute-designated cancer centers' data collection on racial/ethnic minority participation in therapeutic trials: a current view and opportunities for improvement.
    Hawk ET; Habermann EB; Ford JG; Wenzel JA; Brahmer JR; Chen MS; Jones LA; Hurd TC; Rogers LM; Nguyen LH; Ahluwalia JS; Fouad M; Vickers SM
    Cancer; 2014 Apr; 120 Suppl 7(0 7):1113-21. PubMed ID: 24643649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program.
    Kaluzny A; Brawley O; Garson-Angert D; Shaw J; Godley P; Warnecke R; Ford L
    J Natl Cancer Inst; 1993 Dec; 85(23):1945-50. PubMed ID: 8230286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The U.S. pediatric cancer clinical trials programmes: international implications and the way forward.
    Bleyer WA
    Eur J Cancer; 1997 Aug; 33(9):1439-47. PubMed ID: 9337687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrollment of racial/ethnic minorities in NIAID-funded networks of HIV vaccine trials in the United States, 1988 to 2002.
    Djomand G; Katzman J; di Tommaso D; Hudgens MG; Counts GW; Koblin BA; Sullivan PS
    Public Health Rep; 2005; 120(5):543-8. PubMed ID: 16224987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minority Enrollment to Clinical Trials: Road to Increased Access.
    Vose J
    Oncology (Williston Park); 2021 Mar; 35(3):107. PubMed ID: 33818053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
    J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience.
    McCaskill-Stevens W; McKinney MM; Whitman CG; Minasian LM
    J Clin Oncol; 2005 Aug; 23(22):5247-54. PubMed ID: 16051967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The National Cancer Data Base report on patterns of childhood cancers in the United States.
    Grovas A; Fremgen A; Rauck A; Ruymann FB; Hutchinson CL; Winchester DP; Menck HR
    Cancer; 1997 Dec; 80(12):2321-32. PubMed ID: 9404710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013.
    Wissing MD; Kluetz PG; Ning YM; Bull J; Merenda C; Murgo AJ; Pazdur R
    Cancer; 2014 Oct; 120(19):3025-32. PubMed ID: 24965506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in improving mental health services for racial-ethnic minority groups: a ten-year perspective.
    Santiago CD; Miranda J
    Psychiatr Serv; 2014 Feb; 65(2):180-5. PubMed ID: 24178249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation of racial/ethnic groups in clinical trials and race-related labeling: a review of new molecular entities approved 1995-1999.
    Evelyn B; Toigo T; Banks D; Pohl D; Gray K; Robins B; Ernat J
    J Natl Med Assoc; 2001 Dec; 93(12 Suppl):18S-24S. PubMed ID: 11798060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials.
    Sateren WB; Trimble EL; Abrams J; Brawley O; Breen N; Ford L; McCabe M; Kaplan R; Smith M; Ungerleider R; Christian MC
    J Clin Oncol; 2002 Apr; 20(8):2109-17. PubMed ID: 11956272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children's Oncology Group (COG) initiative.
    Sutcliffe MJ; Shuster JJ; Sather HN; Camitta BM; Pullen J; Schultz KR; Borowitz MJ; Gaynon PS; Carroll AJ; Heerema NA
    Leukemia; 2005 May; 19(5):734-40. PubMed ID: 15789069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inclusion of minority groups in clinical trials: problems of under representation and under reporting of data.
    Rochon PA; Mashari A; Cohen A; Misra A; Laxer D; Streiner DL; Clark JP; Dergal JM; Gold J
    Account Res; 2004; 11(3-4):215-23. PubMed ID: 15812967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.